Adiuvo Investments S.A. (ADV.WA)
PLN 1.06
(-3.2%)
PLN 1.06
(-3.2%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -5.07 Million PLN | 89.11% |
| 2022 | -46.71 Million PLN | -97429.17% |
| 2021 | 48 Thousand PLN | 100.58% |
| 2020 | -8.29 Million PLN | 25.35% |
| 2019 | -11.1 Million PLN | 58.15% |
| 2018 | -26.53 Million PLN | 11.11% |
| 2017 | -29.85 Million PLN | -51.28% |
| 2016 | -19.73 Million PLN | -38.45% |
| 2015 | -14.25 Million PLN | -20.23% |
| 2014 | -11.85 Million PLN | -336.31% |
| 2013 | -2.71 Million PLN | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.52 Million PLN | 49.71% |
| 2024 Q1 | -2.44 Million PLN | -68.13% |
| 2023 Q3 | -1.11 Million PLN | 41.68% |
| 2023 Q4 | -1.45 Million PLN | -30.23% |
| 2023 FY | -5.08 Million PLN | 89.11% |
| 2023 Q1 | -409 Thousand PLN | 98.94% |
| 2023 Q2 | -1.91 Million PLN | -368.7% |
| 2022 Q2 | -3.32 Million PLN | -391.86% |
| 2022 Q4 | -38.73 Million PLN | -581.7% |
| 2022 Q3 | -5.68 Million PLN | -70.89% |
| 2022 Q1 | -676 Thousand PLN | -114.28% |
| 2022 FY | -46.71 Million PLN | -97429.17% |
| 2021 FY | 48 Thousand PLN | 100.58% |
| 2021 Q3 | -1.65 Million PLN | 1.72% |
| 2021 Q4 | 4.73 Million PLN | 386.28% |
| 2021 Q1 | -420 Thousand PLN | -165.93% |
| 2021 Q2 | -1.68 Million PLN | -300.71% |
| 2020 Q2 | -3 Million PLN | -137.25% |
| 2020 Q3 | -2.04 Million PLN | 32.07% |
| 2020 FY | -8.29 Million PLN | 25.35% |
| 2020 Q1 | -1.26 Million PLN | -127.88% |
| 2020 Q4 | 637 Thousand PLN | 131.19% |
| 2019 Q1 | -2.77 Million PLN | 67.46% |
| 2019 FY | -11.1 Million PLN | 58.15% |
| 2019 Q4 | -556 Thousand PLN | 73.18% |
| 2019 Q3 | -2.07 Million PLN | 73.54% |
| 2019 Q2 | -7.83 Million PLN | -182.07% |
| 2018 Q4 | -8.53 Million PLN | -50.42% |
| 2018 FY | -26.53 Million PLN | 11.11% |
| 2018 Q2 | -6.76 Million PLN | 4.23% |
| 2018 Q1 | -7.06 Million PLN | 31.09% |
| 2018 Q3 | -5.67 Million PLN | 16.14% |
| 2017 Q4 | -10.25 Million PLN | -61.16% |
| 2017 Q1 | -5.12 Million PLN | 19.48% |
| 2017 FY | -29.85 Million PLN | -51.28% |
| 2017 Q3 | -6.36 Million PLN | 2.45% |
| 2017 Q2 | -6.52 Million PLN | -27.36% |
| 2016 Q2 | -5.33 Million PLN | -60.04% |
| 2016 Q4 | -6.36 Million PLN | -35.35% |
| 2016 FY | -19.73 Million PLN | -38.45% |
| 2016 Q3 | -4.69 Million PLN | 11.99% |
| 2016 Q1 | -3.33 Million PLN | 31.19% |
| 2015 Q4 | -4.84 Million PLN | -41.14% |
| 2015 Q3 | -3.43 Million PLN | -12.18% |
| 2015 FY | -14.25 Million PLN | -20.23% |
| 2015 Q2 | -3.06 Million PLN | -10.5% |
| 2015 Q1 | -2.77 Million PLN | 7.94% |
| 2014 Q1 | -3.16 Million PLN | -7.47% |
| 2014 Q2 | -2.21 Million PLN | 29.97% |
| 2014 Q3 | -3.69 Million PLN | -66.8% |
| 2014 Q4 | -3.01 Million PLN | 18.6% |
| 2014 FY | -11.85 Million PLN | -336.31% |
| 2013 FY | -2.71 Million PLN | 0.0% |
| 2013 Q4 | -2.94 Million PLN | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Genomtec S.A. | -8.72 Million PLN | 41.882% |
| Medinice S.A. | -5.77 Million PLN | 12.234% |
| Medicalgorithmics S.A. | 433 Thousand PLN | 1271.363% |
| Synektik Spólka Akcyjna | 107.81 Million PLN | 104.704% |